Bird Flu Treatment Market to Grow with a CAGR of 8.04% through 2028
Rising incidence of bird flu outbreaks and human
health concerns are expected to drive the Global Bird Flu Treatment Market
growth in the forecast period, 2024-2028
According to TechSci Research report, “Bird Flu
Treatment Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Bird Flu Treatment Market stood
at USD 22.01 billion in 2022 and is anticipated to grow with a CAGR of 8.04% in
the forecast period, 2024-2028. This can be attributed to government
initiatives. Governments and international organizations play a crucial role in
driving the growth of the bird flu treatment market. They have allocated
significant funding for research, surveillance, and the implementation of
preventive measures. These initiatives not only help combat bird flu outbreaks
but also create a conducive environment for market expansion.
Moreover, the One Health approach, which recognizes
the interconnectedness of human, animal, and environmental health, is gaining
traction in the bird flu treatment market. This holistic perspective encourages
collaboration among different sectors to prevent and control avian influenza
more effectively.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Bird
Flu Treatment Market”
The global market for bird flu treatment is
anticipated to experience growth throughout the forecast period. Bird flu, also
known as avian influenza (AI), is a contagious viral disease that primarily
affects birds, particularly ducks and geese living in open water sources. This
virus can also infect poultry and livestock, potentially leading to endemic
outbreaks. While avian influenza is rare in humans, it can occur when
individuals have close contact with infected birds or consume undercooked
poultry products. Some common avian influenza virus subtypes that can infect
humans severely include A(H5N1) and A(H7N9).
Avian flu viruses are classified into high and low
pathogenicity types. People who work in the poultry industry or visit regions
with avian flu outbreaks, have contact with infected birds, or consume raw or
undercooked poultry products face a higher risk of transmission. The A(H5N1)
virus subtype is highly pathogenic and has spread to Asia, Europe, and Africa,
causing significant poultry infections and severe human illnesses. In contrast,
the A(H7N9) subtype is less common and has low pathogenicity, with cases mostly
reported in East Asia. Symptoms of bird flu vary depending on the virus
subtype, and outbreaks can impact the economy and international trade in
affected countries.
Preliminary symptoms of the A(H5N1) virus include high
fever, cough, diarrhea, headache, sore throat, runny nose, and muscle aches,
often progressing to lower respiratory tract issues. A(H7N9) virus symptoms
include shortness of breath, fever, and cough. The primary drivers of growth in
the bird flu treatment market include improved diagnosis due to increased
awareness among infected individuals, leading to early clinical intervention.
The Global Bird Flu Treatment Market is segmented into
type, end-user, regional distribution, and company
Based on its type, the Combination Treatment is poised
to dominate the market share in the Global Bird Flu Treatment Market during the
forecast period for several compelling reasons. First and foremost, it offers a
holistic approach to combating bird flu by combining multiple therapeutic
strategies, which enhances its efficacy in addressing the various strains and
mutations of the virus. This versatility in treatment options allows healthcare
professionals to tailor their approach to the specific needs of each patient,
thus increasing the likelihood of successful outcomes. Additionally, the
Combination Treatment minimizes the risk of antiviral resistance development,
which has been a growing concern in the field. With its potential to deliver
superior results and mitigate resistance issues, it is no surprise that it is
expected to be the preferred choice among healthcare providers and
stakeholders, ultimately securing a substantial market share in the coming
years.
Based on end-user, the Clinics are poised to capture a
significant market share in the Global Bird Flu Treatment Market during the
forecast period for several compelling reasons. First and foremost, their
specialized expertise and state-of-the-art facilities enable them to provide
superior diagnostic and treatment services for bird flu patients. Patients and
healthcare providers alike value the comprehensive care and tailored treatment
plans offered by The Clinics, which have proven to yield better outcomes and
faster recovery times. Furthermore, their established reputation for research
and development in the field of avian influenza positions them as industry
leaders, instilling trust and confidence among stakeholders. As bird flu
continues to pose a global health threat, The Clinics are expected to play a
pivotal role in driving innovation and delivering effective treatments,
cementing their position and dominance in the market.
Major companies operating in Global Bird Flu
Treatment Market are:
- GSK PLC
- Hoffmann-La Roche Inc
- Forest Pharmaceuticals Inc
- BioCryst Pharmaceuticals, Inc.
Download
Free Sample Report
Customers can also request for 10% free customization
on this report
“The Global Bird Flu Treatment Market is poised for
significant transformation as it adapts to emerging trends in vaccine technologies,
antiviral drug development, diagnostic advancements, genomic surveillance,
preparedness and stockpiling, digital health, telemedicine, and the One Health
approach. These trends reflect the industry's commitment to addressing the
ongoing challenges posed by avian influenza and its potential impact on global
health. As research and innovation continue to drive progress, the market is
well-positioned to respond to evolving bird flu threats and protect both animal
and human populations,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Bird Flu Treatment Market By
Type (Antivirals, Combination Treatment,
Prophylactic Antibiotics, Ribavirin), By End-User (Clinics, Hospitals,
Institutional Health Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Bird Flu Treatment Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Bird Flu Treatment Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com